Peter Bigelow to pursue new opportunities from 1 November
Patheon, a global provider of drug development and manufacturing services, says Peter Bigelow, the firm’s president of its North American operations, will leave the company on 1 November to pursue new opportunities.
‘Patheon has benefited immensely from Peter's leadership and is pleased to announce that Peter has agreed to enter into a consulting relationship with the company for a certain period of time to ensure a smooth transition as we continue to focus on the transformation,’ said Jim Mullen, Patheon's ceo.
Bigelow said: ‘I am very proud of what we have accomplished at Patheon. The North American commercial operations continue to have a strong quality record and focus on customer service and I am proud of everyone's efforts in helping us achieve our number two market position in commercial manufacturing worldwide.’